JP2025504496A5 - - Google Patents
Info
- Publication number
- JP2025504496A5 JP2025504496A5 JP2024543357A JP2024543357A JP2025504496A5 JP 2025504496 A5 JP2025504496 A5 JP 2025504496A5 JP 2024543357 A JP2024543357 A JP 2024543357A JP 2024543357 A JP2024543357 A JP 2024543357A JP 2025504496 A5 JP2025504496 A5 JP 2025504496A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210098976 | 2022-01-25 | ||
| CN202210098976.1 | 2022-01-25 | ||
| PCT/CN2023/072527 WO2023143227A1 (zh) | 2022-01-25 | 2023-01-17 | 抗cd73抗体及应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025504496A JP2025504496A (ja) | 2025-02-12 |
| JP2025504496A5 true JP2025504496A5 (https=) | 2026-01-06 |
| JPWO2023143227A5 JPWO2023143227A5 (https=) | 2026-01-06 |
Family
ID=87470540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543357A Abandoned JP2025504496A (ja) | 2022-01-25 | 2023-01-17 | 抗ｃｄ７３抗体及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4471062A4 (https=) |
| JP (1) | JP2025504496A (https=) |
| KR (1) | KR20240139053A (https=) |
| CN (1) | CN118591559A (https=) |
| AU (1) | AU2023212216A1 (https=) |
| WO (1) | WO2023143227A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119744177A (zh) * | 2023-07-24 | 2025-04-01 | 石药集团巨石生物制药有限公司 | 重组人源化抗cd73单克隆抗体的药物组合物 |
| WO2025125545A1 (en) * | 2023-12-15 | 2025-06-19 | Sanofi | Effectorless igg1 fc variants |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3218406T4 (da) | 2014-11-10 | 2024-12-09 | Medimmune Ltd | Bindingsmolekyler, der er specifikke for cd73, og anvendelser deraf |
| MY189836A (en) * | 2014-11-21 | 2022-03-11 | Bristol Myers Squibb Co | Antibodies against cd73 and uses thereof |
| KR20230038311A (ko) * | 2016-03-04 | 2023-03-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-cd73 항체와의 조합 요법 |
| EP3383916B1 (en) | 2017-01-24 | 2022-02-23 | I-Mab Biopharma US Limited | Anti-cd73 antibodies and uses thereof |
| EP3569618A1 (en) * | 2018-05-19 | 2019-11-20 | Boehringer Ingelheim International GmbH | Antagonizing cd73 antibody |
-
2023
- 2023-01-17 EP EP23746109.0A patent/EP4471062A4/en active Pending
- 2023-01-17 CN CN202380018508.1A patent/CN118591559A/zh active Pending
- 2023-01-17 JP JP2024543357A patent/JP2025504496A/ja not_active Abandoned
- 2023-01-17 WO PCT/CN2023/072527 patent/WO2023143227A1/zh not_active Ceased
- 2023-01-17 AU AU2023212216A patent/AU2023212216A1/en active Pending
- 2023-01-17 KR KR1020247024203A patent/KR20240139053A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2026000084A1 (es) | Composiciones herbicidas que comprenden malonamidas y protectores para el control de malezas selectivo en cultivos | |
| JP2025504496A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2025003834A1 (es) | Sistema y método para el control mejorado de una red eléctrica | |
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307045325S (https=) | ||
| BY13145U (https=) | ||
| CN307047624S (https=) | ||
| CN307048021S (https=) | ||
| CN307045938S (https=) | ||
| BY13165U (https=) |